Approval of Central Government for appointment of Managing Director

Management Changes View source PDF Explain this filing

ABBOTINDIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.8%Reaction day

₹29530.00

prior close

₹29560.00

announcement price

In-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.3%+1.2% vs market

Pharmaceuticals peers, median of 154sector-0.8%+1.7% vs sector

On the reaction day the stock moved 1.2 pts more than Nifty Midcap 150 and 1.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

+0.1

15m

+0.1

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.8-0.3+1.2-0.8+1.7

Next day

+1.8-0.1+1.8-0.7+2.5

+1.6+1.2+0.4+0.3+1.3

-0.3+1.2-1.5-0.5+0.1

+2.3+1.1+1.2-0.1+2.4

+1.0+1.0-0.0-0.5+1.4

-2.1-0.1-2.0-0.9-1.2

15d

-5.7-0.1-5.6-1.7-4.0

-2.6+0.4-3.1-1.2-1.4

-6.1-4.7-1.5-9.3+3.2

-10.7-1.5-9.2-9.8-1.0

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Abbott India has received approval from the Central Government (Ministry of Corporate Affairs) under Section 196 of the Companies Act, 2013 for the appointment of Mr. Kartik Rajendran (DIN: 09527717) as Managing Director. The appointment is for a period of 5 years, effective from June 14, 2025 to June 13, 2030. This follows earlier intimation by the company on May 7, 2025 and August 13, 2025 about the proposed appointment. The government order was issued on November 21, 2025 and was communicated to the stock exchange on November 24, 2025.

Likely market impact

The leadership position at Abbott India is now formally confirmed with full regulatory clearance, removing any prior uncertainty around the MD appointment. For shareholders, this provides stability at the top management level for the next five years, though the appointment had likely been in effect since June 2025 already.